Breaking News Instant updates and real-time market news.

2020-12-08 04:55:00 SLP Simulations Plus $57.83 / +0.7 (+1.23%) 04:55 12/08/20 12/08 04:55 12/08/20 04:55	Simulations Plus management to meet virtually with Craig-Hallum Virtual Meeting to be held on December 8 hosted by Craig-Hallum.	08 Dec 17 Dec 06 Aug
SLP Simulations Plus $57.83 / +0.7 (+1.23%) 11/25/20 Taglich Brothers Simulations Plus upgraded to Buy from Speculative Buy at Taglich Brothers 11/17/20 Craig-Hallum Simulations Plus price target raised to $81 from $75 at Craig-Hallum 10/16/20 Raymond James Simulations Plus initiated with an Outperform at Raymond James 10/16/20 Raymond James Simulations Plus initiated with an Outperform at Raymond James

2020-12-08 04:55:00

SLP

Simulations Plus

$57.83 / +0.7 (+1.23%)

04:55

12/08/20

12/08

04:55

12/08/20

04:55

Simulations Plus management to meet virtually with Craig-Hallum

Virtual Meeting to be held on December 8 hosted by Craig-Hallum.

08
Dec
17
Dec

06
Aug

SLP Simulations Plus

$57.83 / +0.7 (+1.23%)

11/25/20 Taglich Brothers: Simulations Plus upgraded to Buy from Speculative Buy at Taglich Brothers

11/17/20 Craig-Hallum: Simulations Plus price target raised to $81 from $75 at Craig-Hallum

10/16/20 Raymond James: Simulations Plus initiated with an Outperform at Raymond James

10/16/20 Raymond James: Simulations Plus initiated with an Outperform at Raymond James

TODAY'S FREE FLY STORIES

Recommendations	Richelieu Hardware price target raised to C$41 from C$40 at CIBC » 11:57 01/22/21 01/22 11:57 01/22/21 11:57 RHUHF Richelieu Hardware $0.00 / + (+0.00%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RHUHF Richelieu Hardware $0.00 / + (+0.00%) 12/16/20 National Bank Richelieu Hardware price target lowered to C$32.50 from C$33.50 at National Bank 12/07/20 National Bank Richelieu upgraded to Sector Perform from Underperform at National Bank 08/25/20 CIBC Richelieu Hardware price target raised to C$37 from C$33 at CIBC 07/13/20 CIBC Richelieu Hardware price target raised to C$33 from C$32 at CIBC
Recommendations	Exchange Income price target raised to C$39.50 from C$37.50 at CIBC » 11:57 01/22/21 01/22 11:57 01/22/21 11:57 EIFZF Exchange Income $0.00 / + (+0.00%) CIBC analyst Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EIFZF Exchange Income $0.00 / + (+0.00%) 01/20/21 National Bank Exchange Income price target raised to C$42 from C$40 at National Bank 11/17/20 Scotiabank Exchange Income price target raised to C$38 from C$32 at Scotiabank 11/16/20 Canaccord Exchange Income price target raised to C$41 from C$36 at Canaccord 11/16/20 RBC Capital Exchange Income price target raised to C$40 from C$36 at RBC Capital
Recommendations	Pembina Pipeline price target raised to C$37 from C$34 at Stifel » 11:56 01/22/21 01/22 11:56 01/22/21 11:56 PBA Pembina Pipeline $27.82 / -0.1843 (-0.66%) Stifel analyst Ian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events PBA Pembina Pipeline $27.82 / -0.1843 (-0.66%) 01/19/21 Pembina Pipeline announces binding open season 12/14/20 Pembina Pipeline sees FY21 CapEx $730M 12/14/20 Pembina Pipeline sees 2021 adjusted EBITDA $3.2B-$3.4B PBA Pembina Pipeline $27.82 / -0.1843 (-0.66%) 01/13/21 CIBC Pembina Pipeline price target raised to C$40 from C$38 at CIBC 12/15/20 BMO Capital Pembina Pipeline downgraded to Market Perform from Outperform at BMO Capital 11/30/20 Wells Fargo Pembina Pipeline downgraded to Equal Weight from Overweight at Wells Fargo 11/19/20 Canaccord Pembina Pipeline price target lowered to C$40 from C$42 at Canaccord 02/26/21 Pembina Pipeline - PBA
Recommendations	K92 Mining price target raised to C$11 from C$9 at BMO Capital » 11:55 01/22/21 01/22 11:55 01/22/21 11:55 KNTNF K92 Mining $0.00 / + (+0.00%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research KNTNF K92 Mining $0.00 / + (+0.00%) 11/30/20 K92 Mining announces results from diamond drilling of Kora deposit KNTNF K92 Mining $0.00 / + (+0.00%) 12/16/20 National Bank K92 Mining initiated with an Outperform at National Bank 10/13/20 Scotiabank K92 Mining price target raised to C$8.50 from C$7.75 at Scotiabank 08/28/20 Canaccord Canaccord backs Buy on K92 Mining after Kora deposit drill results 08/28/20 PI Financial K92 Mining price target raised to C$10 from C$8.25 at PI Financial
Syndicate	Patria opens at $21.50, IPO priced at $17 per share 11:55 01/22/21 01/22 11:55 01/22/21 11:55 PAX Patria $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 22 Jan

Periodicals	EU to see delay of AstraZeneca COVID vaccine delivery, FT reports » 11:53 01/22/21 01/22 11:53 01/22/21 11:53 AZN AstraZeneca $53.07 / +0.54 (+1.03%) The European Union will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $53.07 / +0.54 (+1.03%) 01/20/21 AstraZeneca's Enhertu approved in EU for HER2-positive metastatic breast cancer 01/18/21 AstraZeneca, Daiichi announce FDA approval of Enhertu for gastric cancer 01/15/21 Aveo Pharmaceuticals announces results from portion of DEDUCTIVE trial 01/15/21 AstraZeneca's Imfinzi approved in E.U. and U.K. for additional dosing in NSCLC AZN AstraZeneca $53.07 / +0.54 (+1.03%) 01/19/21 BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG 01/15/21 Berenberg AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg 01/15/21 Fly Intel: Top five analyst initiations 01/15/21 Deutsche Bank AstraZeneca initiated with a Buy at Deutsche Bank AZN AstraZeneca $53.07 / +0.54 (+1.03%) 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year 07/30/20 AstraZeneca backs FY20 mid- to high-teens percentage increase in core EPS 07/30/20 AstraZeneca reports Q2 core EPS 96c, up 31% at CER AZN AstraZeneca $53.07 / +0.54 (+1.03%) 10:38 Today AstraZeneca informs EU Commission of vaccine delivery issues, Bild says 01/17/21 Pakistan approves AstraZeneca COVID vaccine for emergency use, Reuters says 01/15/21 AstraZeneca's COVISHIELD vaccine approved by Nepal, Reuters reports 01/03/21 AstraZeneca/Oxford COVID vaccine authorized by India, WSJ reports AZN AstraZeneca $53.07 / +0.54 (+1.03%) 12/30/20 Fly Intel: Wall Street's top stories for Wednesday 12/30/20 Fly Intel: Wall Street's top stories at midday 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 12/30/20 Fly Intel: Pre-market Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/20/21 PDUFA Date for Tagrisso (Osimertinib) 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN AstraZeneca $53.07 / +0.54 (+1.03%) 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th 12/28/20 Unusually active option classes on open December 28th 12/14/20 AstraZeneca call volume above normal and directionally bullish
Recommendations	Hargreaves Lansdown price target raised to 1,695 GBp at Canaccord » 11:53 01/22/21 01/22 11:53 01/22/21 11:53 HRGLY Hargreaves Lansdown $0.00 / + (+0.00%) Canaccord analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HRGLY Hargreaves Lansdown $0.00 / + (+0.00%) 01/12/21 Morgan Stanley Hargreaves Lansdown price target raised to 1,427 GBp at Morgan Stanley 01/12/21 JPMorgan Hargreaves Lansdown price target raised to 1,450 GBp from 1,390 GBp at JPMorgan 01/08/21 Barclays Hargreaves Lansdown price target lowered to 1,925 GBp at Barclays 01/07/21 Citi Hargreaves Lansdown upgraded to Neutral from Sell at Citi
Recommendations	The Valens Company price target lowered to C$3.75 from C$4 at Desjardins » 11:51 01/22/21 01/22 11:51 01/22/21 11:51 VLNCF The Valens Company $0.00 / + (+0.00%) Desjardins analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research On The Fly VLNCF The Valens Company $0.00 / + (+0.00%) 01/21/21 Stifel The Valens Company price target lowered to C$3.25 from C$3.75 at Stifel 08/12/20 Raymond James The Valens Company downgraded to Market Perform from Outperform at Raymond James 07/17/20 Canaccord The Valens Company price target lowered to C$6 from C$6.50 at Canaccord VLNCF The Valens Company $0.00 / + (+0.00%) 12/17/20 Rising High: 2021 predictions for the cannabis industry
Recommendations	Metro price target lowered to C$65 from C$68 at RBC Capital » 11:50 01/22/21 01/22 11:50 01/22/21 11:50 MTRAF Metro $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MTRAF Metro $0.00 / + (+0.00%) 01/21/21 National Bank Metro price target lowered to C$64 from C$65 at National Bank 01/08/21 TD Securities Metro price target lowered to C$60 from C$62 at TD Securities 11/19/20 CIBC Metro price target raised to C$63 from C$61 at CIBC 11/19/20 RBC Capital Metro price target raised to C$68 from C$66 at RBC Capital
Recommendations	Loblaw price target lowered to C$95 from C$106 at RBC Capital » 11:50 01/22/21 01/22 11:50 01/22/21 11:50 LBLCF Loblaw $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research LBLCF Loblaw $0.00 / + (+0.00%) 01/08/21 TD Securities Loblaw price target lowered to C$70 from C$78 at TD Securities 11/13/20 CIBC Loblaw price target lowered to C$82 from C$85 at CIBC 11/13/20 BMO Capital Loblaw downgraded to Market Perform from Outperform at BMO Capital 11/06/20 RBC Capital Loblaw price target raised to C$106 from C$105 at RBC Capital

Recommendations	George Weston price target lowered to C$133 from C$147 at RBC Capital » 11:49 01/22/21 01/22 11:49 01/22/21 11:49 WNGRF George Weston $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals WNGRF George Weston $0.00 / + (+0.00%) 11/18/20 CIBC George Weston price target lowered to C$122 from C$126 at CIBC 11/18/20 Scotiabank George Weston price target raised to C$117 from C$116 at Scotiabank 11/16/20 BMO Capital George Weston downgraded to Market Perform from Outperform at BMO Capital 11/06/20 RBC Capital George Weston price target raised to C$147 from C$145 at RBC Capital WNGRF George Weston $0.00 / + (+0.00%) 07/30/20 George Weston pursuing acquisition of Aryzta, Bloomberg says
Recommendations	Empire Company price target raised to C$43 from C$42 at RBC Capital » 11:49 01/22/21 01/22 11:49 01/22/21 11:49 EMLAF Empire Company $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EMLAF Empire Company $0.00 / + (+0.00%) 01/08/21 TD Securities Empire Company downgraded to Hold from Buy at TD Securities 12/11/20 CIBC Empire Company price target raised to C$43 from C$42 at CIBC 12/03/20 RBC Capital Empire Company price target raised to C$42 from C$40 at RBC Capital 11/27/20 National Bank Empire Company price target raised to C$43 from C$42 at National Bank
Options	Overstock com call volume above normal and directionally bullish » 11:45 01/22/21 01/22 11:45 01/22/21 11:45 OSTK Overstock.com $68.17 / +4.44 (+6.97%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options OSTK Overstock.com $68.17 / +4.44 (+6.97%) 01/12/21 Overstock.com says Echelon can now trade digital preferred shares 12/28/20 Cryptocurrency mining related names rise after Bitcoin spike this weekend 10/28/20 tZERO signs agreement with Tynton Capital to provide digitization services 10/28/20 Medici Ventures makes additional $8M equity purchase in Bitt OSTK Overstock.com $68.17 / +4.44 (+6.97%) 11/02/20 Wedbush Overstock.com price target raised to $98 from $92 at Wedbush 11/02/20 Wedbush Overstock.com removed from Best Ideas List at Wedbush 10/30/20 Wedbush Overstock.com price target raised to $98 from $92 at Wedbush 10/30/20 Piper Sandler Overstock.com weakness a buying opportunity, says Piper Sandler OSTK Overstock.com $68.17 / +4.44 (+6.97%) 10/29/20 Overstock.com reports Q3 EPS 50c, two est. (23c) 07/30/20 Overstock.com reports Q2 EPS 84c, two est. (8c) 12 Aug OSTK Overstock.com $68.17 / +4.44 (+6.97%) 12/22/20 Overstock eyes potential brick-and-mortar partnerships, AdWeek says OSTK Overstock.com $68.17 / +4.44 (+6.97%) 09:39 Today The Intersection: Crypto and Wall Street This Week 01/15/21 The Intersection: Crypto and Wall Street This Week 01/08/21 The Intersection: Crypto and Wall Street This Week 12/28/20 Fly Intel: Pre-market Movers OSTK Overstock.com $68.17 / +4.44 (+6.97%) 01/12/21 Overstock com call volume above normal and directionally bullish 12/16/20 Unusually active option classes on open December 16th 12/15/20 Overstock com call volume above normal and directionally bullish 11/17/20 Overstock com call volume above normal and directionally bullish
Recommendations	Boyd Gaming price target raised to $60 from $54 at Stifel » 11:41 01/22/21 01/22 11:41 01/22/21 11:41 BYD Boyd Gaming $49.54 / -0.3 (-0.60%) Stifel analyst Steven… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 01/20/21 Nevada extends casino capacity limits through February 14 01/13/21 New Jersey reports December gaming revenue up 8.9% to $312.9M 01/06/21 New York seeking proposals for mobile sports wagering operator 01/06/21 Cuomo seeks 'different model for sports betting' where state gets the sales BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 01/14/21 Truist Boyd Gaming price target raised to $60 from $46 at Truist 01/14/21 KeyBanc KeyBanc bullish on Boyd Gaming, initiates with an Overweight 01/13/21 KeyBanc Boyd Gaming initiated with an Overweight at KeyBanc 01/06/21 Morgan Stanley New York sports betting comments hint at higher tax rate, says Morgan Stanley BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 10/26/20 Boyd Gaming reports Q3 adjusted EPS 38c, consensus 10c 10/26/20 Notable companies reporting after market close 07/28/20 Boyd Gaming reports Q2 EPS (98c), consensus ($1.50) 07/28/20 Notable companies reporting after market close BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games 12/18/20 Ohio sports betting bill fails to reach Senate floor, Play Ohio reports 12/09/20 NY online sports betting could soon be legal, PlayNY says BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 01/15/21 Bet On It: New Jersey handle ranks highest in 2020 01/08/21 Bet On It: New York warming up to online sports betting 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 12/31/20 Bet On It: Rush Street Interactive completes SPAC merger, exceeds expectations 02/16/21 Boyd Gaming - BYD BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 10/26/20 Boyd Gaming options imply 9.7% move in share price post-earnings
Conference/Events	Pacira participates in a conference call with Wedbush » 11:40 01/22/21 01/22 11:40 01/22/21 11:40 PCRX Pacira $68.00 / -1.65 (-2.37%) Emerging Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PCRX Pacira $68.00 / -1.65 (-2.37%) 12/09/20 Pacira reports preliminary November net product sales $38.9M 11/18/20 Pacira receives European Commission approval for EXPAREL 11/16/20 Paulson & Co. buys Lear, cuts Tiffany in Q3 11/11/20 Pacira reports preliminary October net product sales $41.7M PCRX Pacira $68.00 / -1.65 (-2.37%) 01/21/21 SVB Leerink Pacira downgraded to Market Perform from Outperform at SVB Leerink 01/20/21 Piper Sandler Pacira price target raised to $90 from $65 at Piper Sandler 01/06/21 RBC Capital Pacira price target raised to $70 at RBC Capital, named one of 2021 top ideas 12/14/20 Barclays Pacira price target raised to $79 from $73 at Barclays PCRX Pacira $68.00 / -1.65 (-2.37%) 01/07/21 Pacira reports 2020 revenue $429.6M, consensus $427.7M 10/29/20 Pacira reports Q3 adj. EPS 68c, consensus 63c 10/07/20 Pacira reports preliminary Q3 net product sales of $116.9M, consensus $111.86M 08/06/20 Pacira reports preliminary July sales of Exparel of $38.1M 03/22/21 PDUFA Date for EXPAREL

Syndicate	Huadi International opens at $9.01, IPO priced at $8 » 11:37 01/22/21 01/22 11:37 01/22/21 11:37 HUDI Huadi International $0.00 / + (+0.00%) Huadi International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Syndicate	Patria indicated to open at $22, IPO priced at $17 11:28 01/22/21 01/22 11:28 01/22/21 11:28 PAX Patria $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 22 Jan
Initiation	Canada Goose initiated with a Hold at Williams Trading » 11:28 01/22/21 01/22 11:28 01/22/21 11:28 GOOS Canada Goose $31.81 / +0.12 (+0.38%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options GOOS Canada Goose $31.81 / +0.12 (+0.38%) 11/05/20 Canada Goose reports Q2 DTC revenue in mainland China up over 30% 09/30/20 Canada Goose rises 10.2% 08/11/20 Canada Goose is not providing FY21 outlook GOOS Canada Goose $31.81 / +0.12 (+0.38%) 01/05/21 BTIG Canada Goose price target lowered to C$31 from C$35 at BTIG 12/10/20 Goldman Sachs Canada Goose downgraded to Sell from Neutral at Goldman Sachs 11/25/20 Fly Intel: Top five analyst downgrades 11/25/20 BTIG Canada Goose double-downgraded to Sell from Buy at BTIG GOOS Canada Goose $31.81 / +0.12 (+0.38%) 11/05/20 Canada Goose not providing FY21 guidance 11/05/20 Canada Goose reports Q2 adj EPS C$10c vs. C$57c last year 08/11/20 Canada Goose reports Q1 adjusted EPS (C$0.35) vs. (C$0.21) last year 08/11/20 Canada Goose reports Q1 EPS C$46c compared to C$27c GOOS Canada Goose $31.81 / +0.12 (+0.38%) 11/25/20 Fly Intel: Pre-market Movers 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street 09/30/20 Starbucks, Shopify upgrades among today's top calls on Wall Street 08/11/20 Fly Intel: Pre-market Movers GOOS Canada Goose $31.81 / +0.12 (+0.38%) 10/21/20 Canada Goose put volume heavy and directionally bearish 10/12/20 Canada Goose put volume heavy and directionally bearish
Periodicals	YouTube enables HDR support on Xbox gaming systems, Verge reports » 11:27 01/22/21 01/22 11:27 01/22/21 11:27 GOOG Alphabet $1,908.96 / +19.11 (+1.01%) , GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) , MSFT Microsoft $229.52 / +4.63 (+2.06%) Alphabet's (GOOGL)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 06:03 Today Alphabet announces plans to wind down Loon 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 06:03 Today Alphabet announces plans to wind down Loon 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy MSFT Microsoft $229.52 / +4.63 (+2.06%) 10:46 Today Microsoft increases pricing for Xbox Live Gold 09:03 Today SAP, Microsoft expand partnership 01/20/21 EU fines Valve, Capcom, ZeniMax, others EUR7.8M for 'geo-blocking' practices 01/19/21 General Motors jumps 6% to $53.25 after Microsoft invests in Cruise GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 01/21/21 Fly Intel: Top five analyst initiations 01/20/21 Piper Sandler Alphabet assumed with an Overweight at Piper Sandler 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/15/21 MoffettNathanson Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 01/21/21 Fly Intel: Top five analyst initiations 01/20/21 Piper Sandler Alphabet assumed with an Overweight at Piper Sandler 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/19/21 KeyBanc Alphabet price target to $2,060 from $1,970 at KeyBanc MSFT Microsoft $229.52 / +4.63 (+2.06%) 09:31 Today RBC Capital Varonis price target raised to $200 from $165 at RBC Capital 01/21/21 Goldman Sachs Microsoft initiated with a Buy at Goldman Sachs 01/21/21 Cleveland Research Microsoft demand beat expectations in December quarter, says Cleveland Research 01/21/21 Evercore ISI Evercore boosts Microsoft target, adds to 'tactical outperform list' GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago 10/29/20 Alphabet reports Q3 EPS $16.40, consensus $11.29 GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 10/29/20 Alphabet CFO sees signs user behavior beginning to return to normalized level 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago MSFT Microsoft $229.52 / +4.63 (+2.06%) 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B 10/27/20 Microsoft reports Q1 EPS $1.82, consensus $1.54 10/27/20 Notable companies reporting after market close 07/22/20 Microsoft reports Q4 EPS $1.46, consensus $1.37 GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 10:42 Today Waymo CEO: Tesla Autopilot will fall short of full autonomy, Bloomberg reports 06:11 Today Google threatens to close search engine in Australia over news plans, FT reports 01/20/21 Trump pardons engineer Google said stole secrets for Uber, Ars Technica says 01/20/21 EU seeks info from advertisers about Google's ad tech practices, Reuters says GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 10:42 Today Waymo CEO: Tesla Autopilot will fall short of full autonomy, Bloomberg reports 06:11 Today Google threatens to close search engine in Australia over news plans, FT reports 01/20/21 EU seeks info from advertisers about Google's ad tech practices, Reuters says 01/20/21 Google probes actions of ethical AI leader Margaret Mitchell, Axios reports MSFT Microsoft $229.52 / +4.63 (+2.06%) 01/19/21 FireEye releases tool for auditing networks after SolarWinds hack, ZDNet says 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/13/21 Lucasfilm partners with Ubisoft to make open-world 'Star Wars' game, Wired says 01/12/21 Microsoft, others near deals for prime office space in Florida, BI reports GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler MSFT Microsoft $229.52 / +4.63 (+2.06%) 09:34 Today Disney, Ford upgrades among today's top calls on Wall Street 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 02/11/21 Technology & Internet Virtual Conference 01/26/21 Microsoft - MSFT 02/02/21 Alphabet Class A - GOOGL 02/02/21 Alphabet - GOOG GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 11/10/20 Alphabet call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 01/20/21 Early notable gainers among liquid option names on January 20th 10/30/20 Early notable gainers among liquid option names on October 30th 10/21/20 Unusually active option classes on open October 21st 08/27/20 Alphabet Class A call volume above normal and directionally bullish MSFT Microsoft $229.52 / +4.63 (+2.06%) 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th 10/28/20 Notable open interest changes for October 28th 10/27/20 Notable open interest changes for October 27th
Periodicals	SQM shareholders approve $1.1B stock sale, Reuters reports » 11:25 01/22/21 01/22 11:25 01/22/21 11:25 SQM SQM $56.75 / -0.48 (-0.84%) Shareholders of SQM voted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly SQM SQM $56.75 / -0.48 (-0.84%) 10/04/20 Fly Intel: Top five weekend stock stories SQM SQM $56.75 / -0.48 (-0.84%) 12/16/20 SQM upgraded to Outperform at BMO Capital on high lithium price leverage 12/16/20 BMO Capital SQM upgraded to Outperform from Market Perform at BMO Capital 10/21/20 HSBC SQM upgraded to Buy from Hold at HSBC 10/15/20 Deutsche Bank SQM price target raised to $30 from $28 at Deutsche Bank SQM SQM $56.75 / -0.48 (-0.84%) 10/03/20 Albemarle, SQM among best lithium stocks to play EV boom, Barron's says SQM SQM $56.75 / -0.48 (-0.84%) 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day

Options	Takeda Pharmaceutical call volume above normal and directionally bullish » 11:25 01/22/21 01/22 11:25 01/22/21 11:25 TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) 01/21/21 Moderna announces 1st participant dosed in Japan study of Moderna COVID vaccine 12/18/20 Takeda confirms FDA approval of sNDA for Iclusig 12/16/20 Takeda Pharma, Prime Therapeutics sign arrangement for Hemophilia A treatment 12/15/20 FDA accept Takeda NDA for TAK-721, 'specifically' designed for EoE TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham 06/18/20 RBC Capital Neurocrine price target raised to $135 from $116 at RBC Capital 06/17/20 Oppenheimer Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports 08/19/20 Takeda plans to sell OTC drug unit to Blackstone for $2.3B, Nikkei reports TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) 08/24/20 Fly Intel: Wall Street's top stories for Monday 08/24/20 Fly Intel: Wall Street's top stories at midday 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID 08/24/20 Fly Intel: Pre-market Movers 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 01/29/21 Takeda Pharmaceutical Company Ltd
General news	Energy Action: WTI crude » 11:25 01/22/21 01/22 11:25 01/22/21 11:25 Energy Action: WTI crude… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Conference/Events	JPMorgan autos/auto parts analysts hold an analyst/industry conference call » 11:25 01/22/21 01/22 11:25 01/22/21 11:25 Autos & Auto Parts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Initiation	Boot Barn initiated with a Buy at Williams Trading » 11:24 01/22/21 01/22 11:24 01/22/21 11:24 BOOT Boot Barn $57.88 / +0.19 (+0.33%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BOOT Boot Barn $57.88 / +0.19 (+0.33%) 01/08/21 Boot Barn not providing Q4, FY21 guidance amid COVID-19 uncertainty 10/28/20 Boot Barn says Q3 'started well' retail store SSS improving to flat 08/14/20 Boot Barn promotes Greg Hackman to COO 08/05/20 Boot Barn rises 16.6% BOOT Boot Barn $57.88 / +0.19 (+0.33%) 01/14/21 JPMorgan Boot Barn price target raised to $63 from $60 at JPMorgan 01/12/21 Cowen Boot Barn price target raised to $65 from $47 at Cowen 01/11/21 Craig-Hallum Boot Barn price target raised to $48 from $34 at Craig-Hallum 01/11/21 Wells Fargo Boot Barn price target raised to $57 from $49 at Wells Fargo BOOT Boot Barn $57.88 / +0.19 (+0.33%) 01/08/21 Boot Barn reports preliminary Q3 EPS $1.00, consensus 83c 10/28/20 Boot Barn reports Q2 EPS 20c, consensus 12c 08/04/20 Boot Barn reports Q1 EPS (2c), consensus (17c) BOOT Boot Barn $57.88 / +0.19 (+0.33%) 01/06/21 Before the Move: Analysts make pre-announcement predictions ahead of ICR event 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street 10/28/20 Fly Intel: After-Hours Movers 08/04/20 Fly Intel: After-Hours Movers 01/25/21 Boot Barn - BOOT
Initiation	Skechers initiated with a Hold at Williams Trading » 11:22 01/22/21 01/22 11:22 01/22/21 11:22 SKX Skechers $36.27 / -0.46 (-1.25%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SKX Skechers $36.27 / -0.46 (-1.25%) 10/29/20 Skechers not providing guidance due to pandemic 07/23/20 Skechers not providing financial guidance given substantial uncertainty SKX Skechers $36.27 / -0.46 (-1.25%) 01/15/21 B. Riley Securities Skechers price target raised to $44 from $39 at B. Riley Securities 12/10/20 Deutsche Bank Skechers price target raised to $43 from $38 at Deutsche Bank 11/03/20 Susquehanna Skechers downgraded to Neutral from Positive at Susquehanna 10/27/20 Fly Intel: Top five analyst initiations SKX Skechers $36.27 / -0.46 (-1.25%) 10/29/20 Skechers reports Q3 EPS 53c, consensus 36c 07/23/20 Skechers reports Q2 EPS (44c), consensus (66c) 07/23/20 Notable companies reporting after market close SKX Skechers $36.27 / -0.46 (-1.25%) 10/29/20 Fly Intel: After-Hours Movers 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street 07/24/20 Fly Intel: Pre-market Movers 07/23/20 Fly Intel: After-Hours Movers SKX Skechers $36.27 / -0.46 (-1.25%) 10/28/20 Skechers call volume above normal and directionally bullish 09/25/20 Unusual call flow in option market yesterday 09/24/20 Buyers slip into Skechers November calls 07/23/20 Skechers options imply 14.5% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

WAL
Today at 12:00

Western Alliance - WAL Conference Calls
Today at 12:00

Autos & Auto Parts Industry Meetings
FHB
Today at 13:00

First Hawaiian - FHB Conference Calls
ACBI
Today at 13:00

Atlantic Capital - ACBI Conference Calls
BIOL
Today at 14:00

Biolase Inc. Firm Sponsored Meetings

27042 Towne Centre Dr Suite 270, Foothill Ranch, CA
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
PFE
2021-01-24 at 00:00

PDUFA Date for Xalkori (Crizotinib) - January 2021 Government Event
2021-01-24 at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
2021-01-25 at 00:00

Annual Virtual Washington DC Energy & Power Policy Field Trip Conferences

Virtual Field Trip
NAVB
2021-01-25 at 00:00

Navidea Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley Priced at: $4.75 11.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP Priced at: $17.00 30.099M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord Priced at: $49.67 2.013M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities Priced at: $13.00 5.384M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright Priced at: $7.50 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright Priced at: $1.925 51.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Simulations Plus management to meet virtually with Craig-Hallum

TODAY'S FREE FLY STORIES

Get Full Fly Access